Latest news with #AnneBowdidgeabowdidge
Yahoo
21-05-2025
- Business
- Yahoo
Adicet Bio to Participate in a Fireside Chat at the 2025 Jefferies Global Healthcare Conference
REDWOOD CITY, Calif. & BOSTON, May 21, 2025--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that Chen Schor, President and Chief Executive Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference being held from June 3-5, 2025 in New York. Details of the event are as follows:Date: Wednesday, June 4, 2025Time: 4:20 p.m. ET The live audio webcast can be accessed on the Investors section of Adicet Bio's website at An archived replay will be available for 30 days following the presentation. About Adicet Bio, Inc. Adicet Bio, Inc. is a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. Adicet is advancing a pipeline of "off-the-shelf" gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients. For more information, please visit our website at View source version on Contacts Adicet Bio., Inc. Investor and Media Contacts Anne Bowdidgeabowdidge@ Penelope BelnapPrecision Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
30-04-2025
- Business
- Yahoo
Adicet Bio to Participate in a Fireside Chat at the Citizens JMP Life Sciences Conference
REDWOOD CITY, Calif. & BOSTON, April 30, 2025--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that Chen Schor, President and Chief Executive Officer, will participate in a fireside chat at the 2025 Citizens JMP Life Sciences Conference being held from May 7-8, 2025 in New York. Details of the event are as follows:Date: Wednesday, May 7, 2025Time: 1:30 p.m. ET The live audio webcast can be accessed on the Investors section of Adicet Bio's website at An archived replay will be available for 30 days following the presentation. About Adicet Bio, Inc. Adicet Bio, Inc. is a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. Adicet is advancing a pipeline of "off-the-shelf" gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients. For more information, please visit our website at View source version on Contacts Adicet Bio, Inc. Investor and Media Contacts Investors: Anne Bowdidgeabowdidge@ Penelope BelnapPrecision Media: Kerry Beth Dalykbdaly@
Yahoo
29-01-2025
- Business
- Yahoo
Adicet Bio to Participate in a Fireside Chat at the Guggenheim Securities SMID Cap Biotech Conference
REDWOOD CITY, Calif. & BOSTON, January 29, 2025--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that Chen Schor, President and Chief Executive Officer, will participate in a fireside chat at the Guggenheim Securities SMID Cap Biotech Conference being held from February 5-6, 2025 in New York. Details of the event are as follows:Date: Wednesday, February 5, 2025Time: 2:00 p.m. ET The live audio webcast can be accessed on the Investors section of Adicet Bio's website at An archived replay will be available for 30 days following the presentation. About Adicet Bio, Inc. Adicet Bio, Inc. is a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. Adicet is advancing a pipeline of "off-the-shelf" gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients. For more information, please visit our website at View source version on Contacts Adicet Bio, Inc. Investor and Media Contacts Investors: Anne Bowdidgeabowdidge@ Janhavi MohitePrecision Media: Kerry Beth Dalykbdaly@ Sign in to access your portfolio
